How our research benefits to society
Currently too many patients (100 million) develop DFUs, leading to a huge burden on patient health (wound management, pain, immobility). The current focus is on DFU treatment instead of prevention, which also means that healthcare costs are high. The treatment costs for one ulcer are over €10.000. With our focus on prevention, we not only make life easier for patients, but also address this economic burden.
The project is funded by EIT Health, and led by the UMCG. It is part of EXPAND.
Through EIT Health’s network, we are collaborating with different partners to realise our goals.
Together with the University of Coimbra and the Royal Institute of Technology in Stockholm (KTH), and our business partners Lode Holding and OIM Orthopedie, we are working to introduce the solution on the market by the end of the project.